Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (71-80 of 435) with videos related to

Pageof 44
Sort By:
The Journal of Rheumatology|January 17, 2019
The 2018 OMERACT Synovial Tissue Biopsy Special Interest Group Report on Standardization of Synovial Biopsy AnalysisMihir D Wechalekar, Aurélie Najm, Douglas J Veale, et al.
Journal of Managed Care & Specialty Pharmacy|March 27, 2018
Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid ArthritisVibeke Strand, Namita Tundia, Yan Song, et al.
Lupus Science & Medicine|June 28, 2020
Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic reviewVibeke Strand, Lee S Simon, Alexa Simon Meara, et al.
Rheumatology (Oxford, England)|January 12, 2022
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
RMD Open|May 14, 2016
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritisRoy Fleischmann, Vibeke Strand, Bethanie Wilkinson, et al.
Pharmacoeconomics|January 31, 2002
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trialAndreas Maetzel, Vibeke Strand, Peter Tugwell, et al.
Arthritis and Rheumatism|January 11, 2003
Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritisAndreas Maetzel, Vibeke Strand, Peter Tugwell, et al.
Patient Related Outcome Measures|January 23, 2019
Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studiesElvira Bangert, Laura Wakani, Mehveen Merchant, et al.
The Journal of Rheumatology|May 8, 2003
OMERACT workshop: repair of structural damage in rheumatoid arthritisDésirée Van Der Heijde, John T Sharp, Rolf Rau, et al.
Plos One|May 14, 2013
Impact of rheumatoid arthritis disease activity test on clinical practiceJohn W Peabody, Vibeke Strand, Riti Shimkhada, et al.
Pageof 44

Showing results (71-80 of 435) with videos related to

Sort By:
Pageof 44
The Journal of Rheumatology|January 17, 2019
The 2018 OMERACT Synovial Tissue Biopsy Special Interest Group Report on Standardization of Synovial Biopsy AnalysisMihir D Wechalekar, Aurélie Najm, Douglas J Veale, et al.
Journal of Managed Care & Specialty Pharmacy|March 27, 2018
Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid ArthritisVibeke Strand, Namita Tundia, Yan Song, et al.
Lupus Science & Medicine|June 28, 2020
Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic reviewVibeke Strand, Lee S Simon, Alexa Simon Meara, et al.
Rheumatology (Oxford, England)|January 12, 2022
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?Kathleen S Bingham, Vibeke Strand, Lee S Simon, et al.
RMD Open|May 14, 2016
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritisRoy Fleischmann, Vibeke Strand, Bethanie Wilkinson, et al.
Pharmacoeconomics|January 31, 2002
Economic comparison of leflunomide and methotrexate in patients with rheumatoid arthritis: an evaluation based on a 1-year randomised controlled trialAndreas Maetzel, Vibeke Strand, Peter Tugwell, et al.
Arthritis and Rheumatism|January 11, 2003
Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritisAndreas Maetzel, Vibeke Strand, Peter Tugwell, et al.
Patient Related Outcome Measures|January 23, 2019
Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studiesElvira Bangert, Laura Wakani, Mehveen Merchant, et al.
The Journal of Rheumatology|May 8, 2003
OMERACT workshop: repair of structural damage in rheumatoid arthritisDésirée Van Der Heijde, John T Sharp, Rolf Rau, et al.
Plos One|May 14, 2013
Impact of rheumatoid arthritis disease activity test on clinical practiceJohn W Peabody, Vibeke Strand, Riti Shimkhada, et al.
Pageof 44